QURE - Uniqure N.V. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - QURE (1590560)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
34 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2019-05-15
QUREKapusta Matthew CCEO, CFO, MDS - Sale$58.38-8,000415,230-2%-$467,017
2019-04-16
QUREKlemt ChristianChief Accounting OfficerS - Sale$57.18-1,54654,539-3%-$88,400
2019-04-01
QUREAstley-Sparke PhilipDirS - Sale$59.84-6,00019,272-24%-$359,040
M
2019-03-13
QUREKapusta Matthew CCEO, CFO, MDS - Sale$63.96-67,376423,230-14%-$4,309,297
D
2019-02-15
QUREKuta Alexander Edward IIISVP, Regulatory AffairsS - Sale+OE$35.82-8,00038,578-17%-$286,560
2019-01-28
QUREKaye JackDirS - Sale$31.31-1,21014,934-7%-$37,885
2019-01-28
QUREKapusta Matthew CCEO, CFO, MDS - Sale$31.42-19,085490,028-4%-$599,651
2019-01-28
QUREBalachandran MadhavanDirS - Sale$31.31-1,2106,812-15%-$37,885
2019-01-28
QURESoteropoulos PaulaDirS - Sale$31.32-1,21019,934-6%-$37,897
2019-01-28
QURESchaffer DavidDirS - Sale$31.31-1,21045,721-3%-$37,885
2019-01-28
QUREAstley-Sparke PhilipDirS - Sale$31.32-1,21025,272-5%-$37,897
2019-01-28
QUREVan Deventer SanderChief Scientific OfficerS - Sale$31.31-1,35840,313-3%-$42,519
2019-01-28
QUREKlemt ChristianChief Accounting OfficerS - Sale$31.29-1,47956,085-3%-$46,278
2019-01-28
QUREKuta Alexander Edward IIISVP, Regulatory AffairsS - Sale$31.29-1,05226,578-4%-$32,917
2019-01-28
QUREMcMillan Scott T.COOS - Sale$31.23-59120,432-3%-$18,457
2019-01-28
QURESpringhorn Jeremy P.DirS - Sale$31.32-1,2106,812-15%-$37,897
D
2019-01-17
QURESchaffer DavidDirS - Sale+OE$30.71-7,50046,931-14%-$230,325
2019-01-03
QUREKlemt ChristianChief Accounting OfficerS - Sale$27.91-5,73940,000-13%-$160,175
2018-12-03
QUREAstley-Sparke PhilipDirS - Sale$30.39-5,00023,252-18%-$151,950
2018-06-06
QUREZelenkofske StevenChief Medical OfficerS - Sale$37.14-23,929159,458-13%-$888,723
2018-03-15
QUREKapusta Matthew CCEO, CFO, MDS - Sale$21.72-39,169439,764-8%-$850,751
2018-01-29
QURESoteropoulos PaulaDirS - Sale$18.53-2,87817,914-14%-$53,329
2018-01-29
QUREVan Deventer SanderChief Scientific OfficerS - Sale$18.53-5,98525,069-19%-$110,902
2018-01-29
QUREAstley-Sparke PhilipDirS - Sale$18.53-6,54028,252-19%-$121,186
2018-01-29
QUREKaye JackDirS - Sale$18.53-2,87812,914-18%-$53,329
2018-01-29
QURESchaffer DavidDirS - Sale$18.53-2,87815,314-16%-$53,329
2018-01-03
QUREKlemt ChristianChief Accounting OfficerS - Sale$20.13-5,09337,257-12%-$102,510
2018-01-04
QUREKapusta Matthew CCEO, CFO, MDS - Sale$19.87-21,690447,559-5%-$431,069
2018-01-03
QUREGaren JonathanChief Business OfficerS - Sale$20.13-5,86485,251-6%-$118,028
2018-01-03
QUREFiruta Paul EChief Commercial OfficerS - Sale$20.13-5,86485,251-6%-$118,028
2018-01-03
QURECantor Maria ESVP, Investor Relations, CommS - Sale$20.13-5,86485,251-6%-$118,028
DM
2017-06-28
QUREPetry HaraldChief Scientific OfficerS - Sale+OE$6.02-49,3000-100%-$296,568
DM
2017-06-22
QUREPetry HaraldChief Scientific OfficerS - Sale+OE$6.01-65,9300-100%-$396,199
D
2017-03-21
QUREPetry HaraldChief Scientific OfficerS - Sale+OE$6.03-25,4220-100%-$153,290
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top